Eastwood Price To Sales Ratio vs Book Value Per Share Analysis

EBM Stock  CAD 0.75  0.05  6.25%   
Eastwood Bio-Medical financial indicator trend analysis is much more than just examining Eastwood Bio Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eastwood Bio Medical is a good investment. Please check the relationship between Eastwood Bio-Medical Price To Sales Ratio and its Book Value Per Share accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Price To Sales Ratio vs Book Value Per Share

Price To Sales Ratio vs Book Value Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eastwood Bio Medical Price To Sales Ratio account and Book Value Per Share. At this time, the significance of the direction appears to have no relationship.
The correlation between Eastwood Bio-Medical's Price To Sales Ratio and Book Value Per Share is 0.04. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Eastwood Bio Medical Canada, assuming nothing else is changed. The correlation between historical values of Eastwood Bio-Medical's Price To Sales Ratio and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Eastwood Bio Medical Canada are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Price To Sales Ratio i.e., Eastwood Bio-Medical's Price To Sales Ratio and Book Value Per Share go up and down completely randomly.

Correlation Coefficient

0.04
Relationship DirectionPositive 
Relationship StrengthInsignificant

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Eastwood Bio Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eastwood Bio-Medical sales, a figure that is much harder to manipulate than other Eastwood Bio Medical Canada multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.
Most indicators from Eastwood Bio-Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eastwood Bio Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to climb to about 858.4 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.62 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit902.7K440.5K506.6K439.0K
Total Revenue1.3M867.9K998.1K907.6K

Eastwood Bio-Medical fundamental ratios Correlations

0.350.330.60.56-0.41-0.580.98-0.690.580.570.65-0.760.790.320.99-0.560.45-0.840.970.98-0.770.45-0.91-0.880.91
0.351.0-0.54-0.58-0.280.520.46-0.11-0.52-0.50.78-0.730.751.00.36-0.960.11-0.450.260.29-0.290.11-0.28-0.280.2
0.331.0-0.55-0.59-0.260.520.44-0.08-0.53-0.510.76-0.720.751.00.34-0.950.1-0.440.240.27-0.290.1-0.27-0.270.18
0.6-0.54-0.550.99-0.17-0.950.49-0.560.950.93-0.07-0.060.06-0.560.580.310.37-0.350.650.64-0.440.37-0.56-0.540.65
0.56-0.58-0.590.99-0.08-0.970.44-0.480.960.94-0.12-0.010.02-0.60.550.370.3-0.330.60.59-0.440.3-0.54-0.520.61
-0.41-0.28-0.26-0.17-0.08-0.07-0.450.550.070.1-0.520.55-0.34-0.26-0.350.42-0.630.18-0.53-0.460.1-0.630.270.28-0.53
-0.580.520.52-0.95-0.97-0.07-0.460.41-1.0-1.00.180.06-0.120.53-0.58-0.32-0.260.42-0.57-0.570.46-0.260.530.52-0.55
0.980.460.440.490.44-0.45-0.46-0.680.450.450.74-0.810.840.440.98-0.670.39-0.850.960.97-0.730.39-0.89-0.840.89
-0.69-0.11-0.08-0.56-0.480.550.41-0.68-0.41-0.37-0.520.36-0.31-0.08-0.650.32-0.70.44-0.8-0.760.44-0.70.60.62-0.78
0.58-0.52-0.530.950.960.07-1.00.45-0.411.0-0.19-0.050.11-0.540.570.330.26-0.410.560.56-0.460.26-0.52-0.520.54
0.57-0.5-0.510.930.940.1-1.00.45-0.371.0-0.21-0.080.15-0.510.570.310.24-0.430.540.55-0.440.24-0.51-0.50.52
0.650.780.76-0.07-0.12-0.520.180.74-0.52-0.19-0.21-0.720.690.760.67-0.870.27-0.560.670.69-0.610.27-0.7-0.660.61
-0.76-0.73-0.72-0.06-0.010.550.06-0.810.36-0.05-0.08-0.72-0.94-0.72-0.750.86-0.380.77-0.68-0.690.5-0.380.630.6-0.6
0.790.750.750.060.02-0.34-0.120.84-0.310.110.150.69-0.940.750.79-0.850.26-0.850.670.69-0.560.26-0.64-0.610.57
0.321.01.0-0.56-0.6-0.260.530.44-0.08-0.54-0.510.76-0.720.750.34-0.950.1-0.430.230.26-0.280.1-0.26-0.270.17
0.990.360.340.580.55-0.35-0.580.98-0.650.570.570.67-0.750.790.34-0.560.4-0.850.950.97-0.820.4-0.94-0.90.87
-0.56-0.96-0.950.310.370.42-0.32-0.670.320.330.31-0.870.86-0.85-0.95-0.56-0.220.62-0.5-0.520.4-0.220.480.46-0.43
0.450.110.10.370.3-0.63-0.260.39-0.70.260.240.27-0.380.260.10.4-0.22-0.160.510.46-0.291.0-0.27-0.390.5
-0.84-0.45-0.44-0.35-0.330.180.42-0.850.44-0.41-0.43-0.560.77-0.85-0.43-0.850.62-0.16-0.73-0.770.59-0.160.750.68-0.62
0.970.260.240.650.6-0.53-0.570.96-0.80.560.540.67-0.680.670.230.95-0.50.51-0.730.99-0.720.51-0.89-0.860.96
0.980.290.270.640.59-0.46-0.570.97-0.760.560.550.69-0.690.690.260.97-0.520.46-0.770.99-0.780.46-0.93-0.90.93
-0.77-0.29-0.29-0.44-0.440.10.46-0.730.44-0.46-0.44-0.610.5-0.56-0.28-0.820.4-0.290.59-0.72-0.78-0.290.860.96-0.71
0.450.110.10.370.3-0.63-0.260.39-0.70.260.240.27-0.380.260.10.4-0.221.0-0.160.510.46-0.29-0.27-0.390.5
-0.91-0.28-0.27-0.56-0.540.270.53-0.890.6-0.52-0.51-0.70.63-0.64-0.26-0.940.48-0.270.75-0.89-0.930.86-0.270.93-0.82
-0.88-0.28-0.27-0.54-0.520.280.52-0.840.62-0.52-0.5-0.660.6-0.61-0.27-0.90.46-0.390.68-0.86-0.90.96-0.390.93-0.84
0.910.20.180.650.61-0.53-0.550.89-0.780.540.520.61-0.60.570.170.87-0.430.5-0.620.960.93-0.710.5-0.82-0.84
Click cells to compare fundamentals

Eastwood Bio-Medical Account Relationship Matchups

Eastwood Bio-Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets933.4K691.1K584.5K489.1K440.2K418.2K
Other Current Liab384.6K727.0K731.6K1.1M1.0M545.4K
Total Current Liabilities450.9K804.1K844.0K1.3M1.2M605.1K
Total Stockholder Equity459.3K(144.3K)(294.2K)(840.8K)(756.7K)(718.9K)
Net Tangible Assets1.3M459.3K(144.3K)(294.2K)(264.8K)(251.5K)
Current Deferred Revenue6.9K24.1K24.6K72.3K83.1K87.3K
Net Debt(99.4K)10.5K22.4K4.6K5.3K5.6K
Retained Earnings(4.2M)(4.8M)(5.0M)(5.5M)(5.0M)(4.7M)
Accounts Payable59.3K53.0K60.3K101.7K117.0K122.8K
Cash122.7K20.9K39.8K18.4K16.6K15.8K
Cash And Short Term Investments122.7K20.9K39.8K18.4K16.6K15.8K
Net Receivables9.7K6.0K14.6K82.8K74.5K70.8K
Liabilities And Stockholders Equity933.4K691.1K584.5K489.1K440.2K418.2K
Other Current Assets40.2K31.0K47.0K49.7K44.8K42.5K
Total Liab474.1K835.4K878.7K1.3M1.2M611.6K
Total Current Assets172.6K57.9K101.5K151.0K135.9K129.1K
Non Current Assets Total760.8K633.3K483.1K338.2K388.9K458.8K
Non Currrent Assets Other402.4K111.2K83.4K37.1K42.6K40.5K
Net Invested Capital482.5K(113.0K)(231.9K)(778.8K)(700.9K)(665.9K)
Net Working Capital(278.3K)(746.2K)(742.5K)(1.2M)(1.1M)(1.0M)
Property Plant And Equipment Net649.6K549.9K446.0K338.2K388.9K495.5K
Property Plant Equipment456.6K649.6K549.9K446.0K512.9K520.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.